Floatz logo

Enalapril

Precursor-cell Lymphoblastic Leukemia-Lymphoma

Hospital Clinic of BarcelonaSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Precursor-cell Lymphoblastic Leukemia-Lymphoma cohort.

Asset / SponsorPhaseRating
CARVEDILOL
Hospital Clinic of Barcelona
Phase 3BB

Same molecule, other indications

Enalapril is also rated in:

essential hypertensionDormant
BB
Indicative ·
67 / 100
View asset →
hypertensive disorderDormant
BB
Indicative ·
65 / 100
View asset →
diabetes mellitusDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →